Neuropeptide Treatment for Hot Flushes During the Menopause

计划入组 37 人 · 首次发布于 2016 年 1 月 29 日

A Study of AZD4901 in Females With Polycystic Ovary Syndrome

计划入组 67 人 · 首次发布于 2013 年 6 月 7 日

Ultrashort GnRH Agonist/Antagonist Versus GnRH Antagonist IVF

计划入组 200 人 · 首次发布于 2014 年 6 月 25 日

NLRP3 antagonist

RORC antagonist

Antagonist-G

Anebulo Pharmaceuticals

United States

Adial Pharmaceuticals

United States

Relmada Therapeutics

United States

Hot Flashes Treatment Pipeline Expands with 15+ Novel Therapies from Leading Pharmaceutical Companies

Bonafide Health Launches Thermella, a Hormone-Free NK3R Antagonist for Menopause

Oral CCR4 Antagonist RPT193 Shows Promise in Atopic Dermatitis Phase 1 Trial